Personalized immune cell therapy tested as potential lifeline for Tough-to-Treat adult leukemia
Disease control
Ongoing
This study is testing a personalized cell therapy called AUTO1 for adults with a type of blood cancer (B-cell ALL) that has come back or hasn't responded to other treatments. Doctors take a patient's own immune cells, modify them in a lab to better target cancer cells, and then i…
Phase: PHASE1, PHASE2 • Sponsor: Autolus Limited • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC